Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invicta DiagnosticNSE:INVICTA +3.88%22 FCF Yield % is -11.46 as of Aug. 20, 2026. GuruFocus rates NSE:INVICTA with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, Invicta Diagnostic ranks worse than 72.64% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Invicta Diagnostic's FCF Yield % or its related term are showing as below:
NSE:INVICTA'
s FCF Yield % Range Over the Past 10 Years
Min: -16.71 Med: -11.14 Max: 7.7
Current: -11.46
During the past 3 years, the highest FCF Yield % of Invicta Diagnostic was 7.70%. The lowest was -16.71%. And the median was -11.14%.
NSE:INVICTA's FCF Yield % is ranked worse than 72.64% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.44
vs NSE:INVICTA: -11.46
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Invicta Diagnostic FCF Yield % Related Terms
Invicta Diagnostic FCF Yield % Historical Data
* Premium members only.
The historical data trend for Invicta Diagnostic's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invicta Diagnostic FCF Yield % Chart
Invicta Diagnostic Annual Data
Trend
Mar24
Mar25
Mar26
FCF Yield %
0.00
0.00
-12.66
Invicta Diagnostic Semi-Annual Data
Mar24
Mar25
Sep25
Mar26
FCF Yield %
0.00
0.00
0.00
-19.38
NSE:INVICTA vs TMO, DHR, IDXX: FCF Yield % Comparison
For the Diagnostics & Research subindustry, Invicta Diagnostic's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invicta Diagnostic FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invicta Diagnostic's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Invicta Diagnostic's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invicta Diagnostic (NSE:INVICTA) has a FCF Yield % of -11.46 as of Aug. 20, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Invicta Diagnostic and its competitors. According to the industry distribution chart, Invicta Diagnostic ranks #154 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 72.6%.
Is Invicta Diagnostic's FCF Yield % too high?
Invicta Diagnostic's current FCF Yield % is -11.46. Based on the distribution chart, Invicta Diagnostic ranks #154 out of 212 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Invicta Diagnostic has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Invicta Diagnostic's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Invicta Diagnostic ranks #154 out of 212 companies for FCF Yield %. This places Invicta Diagnostic in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Invicta Diagnostic and its competitors. Invicta Diagnostic's current FCF Yield % is -11.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invicta Diagnostic stock overvalued right now?
Invicta Diagnostic (NSE:INVICTA) has a current FCF Yield % of -11.46. The current FCF Yield % is -11.46. Invicta Diagnostic's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Invicta Diagnostic (NSE:INVICTA), the current FCF Yield % is -11.46 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invicta Diagnostic Ltd is engaged in the business of medical and diagnostic services and operates diagnostic centres providing medical testing and allied healthcare services in the Mumbai Metropolitan Region. The Company runs a diagnostic chain comprising seven diagnostic centres and one centralised laboratory across MMR in Maharashtra and operates under a hub and spoke model with a flagship hub in Thane, additional hub centres, spoke centres, and a centralised laboratory. Its service offerings include radiology and imaging, pathology and clinical laboratory tests, teleradiology, and services such as ultrasound, X Ray, CT scan, MRI scan, PET scan, and cardiac diagnostics, with patient convenience supported through home sample collection, house calls, and multiple report delivery options.
22GF Score
Get the complete analysis for NSE:INVICTA
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INVICTA has been successfully added to your 
